In this video, Anum Minhas, MD, MHS, discusses recommendations for contraceptives in women with heart disease, obesity, high blood pressure, or diabetes in a cardiology setting, including dependable...
In this video, Michael J. Bloch, MD, discusses the link between combined oral contraceptives and increased risk of arterial thrombosis, the risk of venous thromboembolic disease, and...
In this video, Michael J. Bloch, MD, discusses the use of combined oral contraceptives, which are the most common forms of birth control used by women in the United States, oral estrogen-free progestin-only...
In this video, Michael J. Bloch, MD, discusses any cardiovascular benefits to the use of estrogen-free oral contraceptives in women, including a recently published study on the association of menstrual...
In this interview, Jacob C. Jentzer, MD, assistant professor of medicine in the Department of Cardiovascular Medicine at the Mayo Clinic in Rochester, Minnesota discusses the implications of his study and...
In this video, Michael J. Bloch, MD, discusses the implications of a recently published study on the association of menstrual cycle regularity and length with cardiovascular diseases, including gaps in the...
In this video, Michael J. Bloch, MD, reviews and discusses a recently published study on the association of menstrual cycle regularity and length with cardiovascular diseases, including how the results...
In this article, Michael J Bloch, MD, discusses the usage of RAS-blocking agents, slowing the progression of end-stage renal disease, and reducing cardiovascular events in patients with advanced kidney...
In this podcast, Alan S. Go, MD, discusses the results of his recent study, which examined the relationship between HIV, heart failure, and patient demographics.
In this article, Michael Bloch, MD, and Evan Bloch discuss findings from the SELECT trial, including the use of the glucagon-like peptide 1 receptor agonist, semaglutide, to reduce the risk of major...
